Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from YU135988Aexternal-prioritypatent/YU46920B/en
Application filed by Erba Carlo SpafiledCriticalErba Carlo Spa
Priority to HR921220ApriorityCriticalpatent/HRP921220B1/en
Publication of HRP921220A2publicationCriticalpatent/HRP921220A2/en
Publication of HRP921220B1publicationCriticalpatent/HRP921220B1/en
Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin to 4'-deoxy-13(s)-dihydro-4'-iododoxorubicin